English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 製薬企業関連 > 世界の癌治療薬開発企業ディレクトリ
カテゴリ
医薬品 (4955)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (182)
感染症 (351)
規制環境 (130)
後発医薬品 (134)
骨疾患 (37)
処方薬 (157)
神経疾患 (174)
精神疾患 (88)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

世界の癌治療薬開発企業ディレクトリ

Global Cancer Focus Company Directory

発行 BioSeeker Group AB
出版日 2007年04月 商品コード 51914
ページ情報 英文  
価格
US$ 2,828 換算 ¥ 228,191 (税抜) PDF by E-mail (Single User License)


原文目次

Abstract

Executive Summary

Global Cancer Focus Company Directory pulls out virtually all cancer drug developing companies in the world. After several acquisitions and mergers in the market place, BioSeeker offers you the tool to get an updated look on the competitive landscape in oncology, including almost 900 hundred companies in 39 different countries. Global Cancer Focus Company Directory breaks down all companies into their involvement in 81 different cancer indications, also including supportive care and diagnosis.

Global Cancer Focus Company Directory is a CD-ROM product with a 98 pages supplementary PDF included. The CD-ROM product is based on BioSeeker' s proprietary CD-ROM technology which includes smart database structure, find and sort options, internet and e-mail interactivity. Found information on the CD-ROM may easily be shared with others via file export (txt and xls), e-mail or print.

Each company profile reports on:

  • Cancer Focus (Includes 81 different cancer indications)
  • Year Founded
  • Ownership (Private/Public)
  • Contact details (Address, Phone, Fax, Web and E-mail)
  • A brief company description
  • All companies are provided with links, which connect you directly to the company webpage for further research. Companies can be further researched on from inside the application by linking search queries directly to search engines like Google and PubMed.

How May This Product Be of Use?

  • Comprehensive source of oncology companies
  • Find new and emerging companies in oncology
  • Find out your potential competitors, partners, M&A candidates etc. on a cancer indication specific level
  • Jump start competitive intelligence operations
  • Excellent starting point for world-wide benchmarking
  • Speed up pro-active in-/out-licensing strategy work
  • Track companies over time using search engines
  • Show investors/board/management that you are right on top of industry development

System Requirements

  • AMD-Athlon/Pentium II PC
  • Windows 98/NT4/2000/ME/XP/Vista
  • 8x-speed CD Rom drive
  • SVGA 16 bit display. (32 bit recommended)
  • 32 MB of available RAM (128 MB recommended)
  • Internet access (to test web-enabled presentations)

Table of Contents

  • Executive Summary
  • Table of Contents
  • Cancer Highlights
  • Latest Acquisitions, Mergers and Bankruptcies in the Oncology Arena
  • New Emerging Oncology Companies
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
  • Oncology Companies by Country
    • Argentina
    • Australia
    • Austria
    • Belgium
    • Bermuda
    • Brazil
    • Canada
    • China
    • Croatia
    • Cuba
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Greece
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Ireland
    • Israel
    • Italy
    • Japan
    • New Zealand
    • Norway
    • Philippines
    • Portugal
    • Russia
    • Singapore
    • South Korea
    • Spain
    • Sweden
    • Switzerland
    • Taiwan
    • United Kingdom
    • USA
  • Companies by Cancer Indications
    • Benign prostatic hyperplasia
    • Cancer fatigue
    • Cancer, basal cell
    • Cancer, biliary
    • Cancer, bladder
    • Cancer, bone
    • Cancer, brain
    • Cancer, breast
    • Cancer, carcinoid
    • Cancer, carcinoid syndrome
    • Cancer, cervical
    • Cancer, CNS
    • Cancer, colorectal
    • Cancer, endometrial
    • Cancer, esophageal
    • Cancer, gastrointestinal, general
    • Cancer, gastrointestinal, stomach
    • Cancer, gastrointestinal, stromal
    • Cancer, head and neck
    • Cancer, leukemia, acute lymphocytic
    • Cancer, leukemia, acute myelogenous
    • Cancer, leukemia, chronic lymphocytic
    • Cancer, leukemia, chronic myelogenous
    • Cancer, leukemia, general
    • Cancer, leukemia, hairy cell
    • Cancer, liver
    • Cancer, lung, general
    • Cancer, lung, non-small cell
    • Cancer, lung, small cell
    • Cancer, lymphoma, B-cell
    • Cancer, lymphoma, general
    • Cancer, lymphoma, Hodgkin`s
    • Cancer, lymphoma, non-Hodgkin`s
    • Cancer, lymphoma, T-cell
    • Cancer, melanoma
    • Cancer, mesothelioma
    • Cancer, myeloma
    • Cancer, myeloma, multiple
    • Cancer, myoma
    • Cancer, nasopharyngeal
    • Cancer, neuroendocrine
    • Cancer, oesophageal
    • Cancer, oral
    • Cancer, ovarian
    • Cancer, pancreatic
    • Cancer, peritoneal
    • Cancer, prostate
    • Cancer, renal
    • Cancer, renal, cell carcinoma
    • Cancer, sarcoma, general
    • Cancer, sarcoma, Kaposi`s
    • Cancer, sarcoma, leiomyo
    • Cancer, skin, general
    • Cancer, solid tumor
    • Cancer, squamous cell
    • Cancer, testicular
    • Cancer, therapy adjuvant
    • Cancer, thyroid
    • Chemotherapy-induced alopecia
    • Chemotherapy-induced eczema
    • Chemotherapy-induced infection
    • Chemotherapy-induced injury, bone marrow, general
    • Chemotherapy-induced injury, bone marrow, leucopenia
    • Chemotherapy-induced injury, bone marrow, neutropenia
    • Chemotherapy-induced injury, bone marrow, thrombocytopenia
    • Chemotherapy-induced injury, general
    • Chemotherapy-induced injury, GI
    • Chemotherapy-induced injury, renal
    • Chemotherapy-induced mucositis
    • Chemotherapy-induced nausea and vomiting
    • Diagnosis, cancer
    • Dysplasia, anal
    • Dysplasia, cervical
    • Fibrocystic breast disorder
    • Myelodysplastic syndrome
    • Myelofibrosis, myeloid metaplasia
    • Pain, cancer
  • Disclaimer
  • Liability
  • Completeness
Back to Top